Novel derivatives of usnic acid effectively inhibiting reproduction of influenza A virus

被引:46
作者
Shtro, Anna A. [1 ]
Zarubaev, Vladimir V. [1 ]
Luzina, Olga A. [2 ]
Sokolov, Dmitry N. [2 ]
Kiselev, Oleg I. [1 ]
Salakhutdinov, Nariman F. [2 ]
机构
[1] All Union Influenza Res Inst, St Petersburg, Russia
[2] Russian Acad Sci, Novosibirsk Organ Chem Inst, Siberian Branch, Novosibirsk 630090, Russia
基金
俄罗斯基础研究基金会;
关键词
Usnic acid; Usnic acid derivatives; Influenza; Anti-viral activity; LICHEN SECONDARY METABOLITES; 2009 PANDEMIC INFLUENZA; (+)-USNIC ACID; IN-VITRO; CHEMICAL-MODIFICATION; CYTOTOXIC ACTIVITIES; (-)-USNIC ACID; PROPHYLAXIS; A(H1N1)2009; RESISTANT;
D O I
10.1016/j.bmc.2014.10.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Influenza virus is serious human pathogen leading to high morbidity and mortality all over the world. Due to high rate of mutation, it is able to fast development of drug resistance that makes necessary to search novel antivirals with broad range and alternative targets. In the present study we describe synthesis and anti-viral activity of novel derivatives of usnic acid (2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-1,3( 2H, 9bH)-dibenzo-furandione). It is shown that anti-viral activity of usnic acid can be increased by side moieties introduction. The modification with chalcones appeared to be the most effective. Our study revealed that (-)-usnic acid exhibited higher antiviral activity than its (+)-enantiomer, but in the pairs of enantiomer derivatives such as enamines, pyrazoles and chalcones, the (+)-enantiomers were more potent inhibitors of the virus. For other groups of compounds the inhibiting activities of the enantiomers were comparable. Further optimization of the structure could therefore result in development of novel anti-influenza compound with alternative target and mechanism of virus-inhibiting action. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6826 / 6836
页数:11
相关论文
共 50 条
[31]   Usnic acid: a non-genotoxic compound with anti-cancer properties [J].
Mayer, M ;
O'Neill, MA ;
Murray, KE ;
Santos-Magalhaes, NS ;
Carneiro-Leao, AMA ;
Thompson, AM ;
Appleyard, VCL .
ANTI-CANCER DRUGS, 2005, 16 (08) :805-809
[32]  
Pebody R, 2011, EUROSURVEILLANCE, V16, P8
[33]   Antimicrobial, antiviral and cytotoxic activity of New Zealand lichens [J].
Perry, NB ;
Benn, MH ;
Brennan, NJ ;
Burgess, EJ ;
Ellis, G ;
Galloway, DJ ;
Lorimer, SD ;
Tangney, RS .
LICHENOLOGIST, 1999, 31 :627-636
[34]   Effect of Usnic Acid on Candida orthopsilosis and C. parapsilosis [J].
Pires, Regina Helena ;
Lucarini, Rodrigo ;
Soares Mendes-Giannini, Maria Jose .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (01) :595-597
[35]  
Polovinka M. P., 2008, [RF Pat, Byull. Izobret], Patent No. [2,317,076, 5, 4, 2317076, 2, 317, 076C1]
[36]   Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria [J].
Ramos, Daniela Fernandes ;
Almeida da Silva, Pedro Eduardo .
PHARMACEUTICAL BIOLOGY, 2010, 48 (03) :260-263
[37]  
Salakhutdinov NF, 2008, B IZOBRET, Patent No. 2,317,076C1
[38]  
Scirpa P, 1999, Minerva Ginecol, V51, P255
[39]  
Shibata S., 1956, CHEM PHARM, V4, P65
[40]   Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009 [J].
Skowronski, Danuta M. ;
Janjua, Naveed Z. ;
De Serres, Gaston ;
Hottes, Travis S. ;
Dickinson, James A. ;
Crowcroft, Natasha ;
Kwindt, Trijntje L. ;
Tang, Patrick ;
Charest, Hugues ;
Fonseca, Kevin ;
Gubbay, Jonathan B. ;
Bastien, Nathalie ;
Li, Yan ;
Petric, Martin .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342 :c7297